Proteinase-activated Receptor-2 Transactivation of Epidermal Growth Factor Receptor and Transforming Growth Factor-β Receptor Signaling Pathways Contributes to Renal Fibrosis-Reference-Cited by-同舟云学术

Proteinase-activated Receptor-2 Transactivation of Epidermal Growth Factor Receptor and Transforming Growth Factor-β Receptor Signaling Pathways Contributes to Renal Fibrosis

Published:2013-12 Issue:52 Volume:288 Page:37319-37331
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Chung Hyunjae,Ramachandran Rithwik,Hollenberg Morley D.,Muruve Daniel A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference51 articles.

1. Incidence and outcomes in acute kidney injury. A comprehensive population-based study;Ali;J. Am. Soc. Nephrol,2007

2. Molecular basis of renal fibrosis;Eddy;Pediatr. Nephrol,2000

3. Serine proteases, inhibitors and receptors in renal fibrosis;Eddy;Thromb. Haemost,2009

4. Targeting proteinase-activated receptors. Therapeutic potential and challenges;Ramachandran;Nat. Rev. Drug Discov,2012

5. Protease-activated receptor 2 signaling in inflammation;Rothmeier;Semin. Immunopathol,2012

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies;Frontiers in Pharmacology;2024-08-21

2. Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase—Bridging Basic Research to Clinical Findings;Biomolecules;2024-08-07

3. PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu;Frontiers in Pharmacology;2024-06-28

4. Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) as a Prognostic Biomarker in Acute Kidney Injury: A Narrative Review;Diagnostics;2024-06-25

5. The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis;Molecular Metabolism;2024-03